Clinical Trial Update: Rhodiola Rosea for Coronary Microvascular Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on Rhodiola Rosea for Coronary Microvascular Disease spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Microvascular Disease

Drugs mentioned

• Rhodiola Rosea

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Coronary Microvascular Disease | Phase 2, Phase 3 | Status: UNKNOWN